ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	3/22	30/7206	9.50783841534e-05
ko04064	NF-kappa B signaling pathway	4/22	96/7206	0.000180022133786
ko05145	Toxoplasmosis	3/22	126/7206	0.00630524069347
ko05144	Malaria	2/22	45/7206	0.00813669572506
ko05164	Influenza A	3/22	167/7206	0.0136204975625
ko00600	Sphingolipid metabolism	2/22	63/7206	0.0155285912805
ko05152	Tuberculosis	3/22	187/7206	0.0184205179411
ko05202	Transcriptional misregulation in cancer	3/22	188/7206	0.0186824094118
ko04612	Antigen processing and presentation	2/22	77/7206	0.022674736964
ko05169	Epstein-Barr virus infection	3/22	206/7206	0.0237567329754
ko04658	Th1 and Th2 cell differentiation	2/22	96/7206	0.0341287362695
ko04650	Natural killer cell mediated cytotoxicity	2/22	97/7206	0.0347835651457
ko04620	Toll-like receptor signaling pathway	2/22	100/7206	0.0367776766474
ko04659	Th17 cell differentiation	2/22	106/7206	0.0408962382222